Clinical Trials Browser

Phase 2 × Unknown × Prostatic Neoplasms, Castration-Resistant × Clear all

NCT05156450 2021-12-14

TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms, Castration-Resistant

NCT02254785 2017-12-06

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms, Castration-Resistant